Walmart, Costco, and Amazon are increasingly positioning themselves as key players in the weight loss drug market by offering direct-to-consumer programs for medications like Wegovy and Zepbound. This comes as some employers are reducing or eliminating coverage for these drugs under health insurance plans. The shift reflects growing demand for weight management solutions and the potential for retailers to capture a larger share of the healthcare market. Retailers are leveraging their extensive customer bases and infrastructure to streamline access to these medications, potentially altering traditional healthcare delivery models.
Bias read (Center): The article presents a factual overview of market trends involving major retailers and pharmaceutical drugs, without overtly favoring any particular political ideology. It focuses on economic and corporate strategy rather than ideological positions, though the implications touch on broader issues of






